Breakthrough Anxiety and Sleep Evaluation Using Linked Devices and Smartphone Application Onar (BASEL)
Study Details
Study Description
Brief Summary
Sleep is not simply the absence of wakefulness. Sleep is an active procedure, normally happening every night, and is absolutely vital. Good sleep is essential for our well-being. Survival without food can be further than without sleep. Work time and commuting time seem to affect total sleep time and night bedtime. Social and work obligation can, therefore, suppress sleep time. Sleep deprived individuals may be facing anxiety and depression symptoms.
The aim of this study is to investigate the presence of anxiety and depression symptoms among adults with the use of the smartphone application Onar. Onar app will be used to gather information from wearable devices of the users including total sleep time, sleep efficiency, wake after sleep onset time. An established questionnaire (Hospital Anxiety Depression Scale/ HADS) will be used to quantify and detect the presence of anxiety and depression in the study population.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Outcome Measures
Primary Outcome Measures
- To determine the existence of depression and anxiety symptoms in the study population. [2 weeks]
Comparison of HADS score with population standardized mean value.
Secondary Outcome Measures
- Correlation of depression and anxiety symptoms with Total sleep time (TST). [2 weeks]
Total sleep time (TST).
- Correlation of depression and anxiety symptoms with Wake after sleep onset time (WASO). [2 weeks]
Wake after sleep onset time (WASO).
- Correlation of depression and anxiety symptoms with Sleep Onset Latency (SOL). [2 weeks]
Sleep Onset Latency (SOL).
- Correlation of depression and anxiety symptoms with Epworth Sleepiness Scale (ESS). [2 weeks]
Epworth Sleepiness Scale (ESS).
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Acceptance of terms of use of the application must be done prior to participation in the study.
-
Male and female adults aged ≥18 years old and ≤60 years old.
-
Subjects using the application on a daily basis for at least 1 week prior to participation.
Exclusion Criteria:
- History of alcohol or other substance abuse.
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Raivotech
Investigators
- Principal Investigator: Kyriakos Karkoulias, Prof., University Hospital of Patras, Greece
Study Documents (Full-Text)
None provided.More Information
Publications
- Bixler EO, Vgontzas AN, Lin HM, Calhoun SL, Vela-Bueno A, Kales A. Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab. 2005 Aug;90(8):4510-5. doi: 10.1210/jc.2005-0035. Epub 2005 Jun 7.
- Horenstein A, Morrison AS, Goldin P, Ten Brink M, Gross JJ, Heimberg RG. Sleep quality and treatment of social anxiety disorder. Anxiety Stress Coping. 2019 Jul;32(4):387-398. doi: 10.1080/10615806.2019.1617854. Epub 2019 May 13.
- Sforza E, de Saint Hilaire Z, Pelissolo A, Rochat T, Ibanez V. Personality, anxiety and mood traits in patients with sleep-related breathing disorders: effect of reduced daytime alertness. Sleep Med. 2002 Mar;3(2):139-45. doi: 10.1016/s1389-9457(01)00128-9.
- Snaith RP. The Hospital Anxiety And Depression Scale. Health Qual Life Outcomes. 2003 Aug 1;1:29. doi: 10.1186/1477-7525-1-29.
- ROA101